{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:57:59Z","timestamp":1787065079814,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jhlto.2026.100513","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:39:09Z","timestamp":1771054749000},"page":"100513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Glucagon-like peptide-1 receptor agonist use and clinical outcomes after lung transplantation: A single-center cohort study"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-3823","authenticated-orcid":false,"given":"Yudai","family":"Miyashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1056-5929","authenticated-orcid":false,"given":"Taisuke","family":"Kaiho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reichenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-1463","authenticated-orcid":false,"given":"Yuriko","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambalavan","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3536-4675","authenticated-orcid":false,"given":"Chitaru","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2026.100513_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100513_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(18)30024-X","article-title":"Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial","volume":"6","author":"Pratley","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhlto.2026.100513_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhlto.2026.100513_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100513_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"28","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100513_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2026.100513_bib7","first-page":"47","article-title":"Cardiovascular disease and risk management: standards of care in diabetes\u20142024","volume":"1","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhlto.2026.100513_bib8","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.2337\/dc25-S011","article-title":"Chronic kidney disease and risk management: standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhlto.2026.100513_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhlto.2026.100513_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/nu13020369","article-title":"Malnutrition according to GLIM criteria is associated with mortality and hospitalizations in rehabilitation patients with stable chronic obstructive pulmonary disease","volume":"13","author":"D\u00e1valos-Yerovi","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jhlto.2026.100513_bib11","first-page":"250","article-title":"Prevalence of malnutrition in outpatients with stable chronic obstructive pulmonary disease","volume":"40","author":"Soler","year":"2004","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.jhlto.2026.100513_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/TP.0000000000003823","article-title":"Frailty measures in patients listed for lung transplantation","volume":"106","author":"Montgomery","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2026.100513_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00595-023-02765-y","article-title":"Association of the psoas muscle index with the survival of patients on a waiting list for lung transplantation: a Japanese single-institution study","volume":"54","author":"Matsui","year":"2023","journal-title":"Surg Today"},{"key":"10.1016\/j.jhlto.2026.100513_bib14","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jtcvs.2017.11.031","article-title":"Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score","volume":"155","author":"Fernandez","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhlto.2026.100513_bib15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/bph.16278","article-title":"Newer pharmacological interventions directed at gut hormones for obesity","volume":"181","author":"Camilleri","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhlto.2026.100513_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00325481.2020.1798099","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date","volume":"132","author":"Brunton","year":"2020","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jhlto.2026.100513_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bph.15647","article-title":"Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?","volume":"179","author":"Borner","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhlto.2026.100513_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","article-title":"Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jhlto.2026.100513_bib19","first-page":"36","article-title":"Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or post-transplant diabetes","volume":"6","author":"Mahzari","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jhlto.2026.100513_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LVT.0000000000000247","article-title":"Semaglutide is effective in achieving weight loss in liver transplant recipients","volume":"30","author":"Chow","year":"2024","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhlto.2026.100513_bib21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.23876\/j.krcp.24.271","article-title":"Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis","volume":"44","author":"Usman","year":"2025","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jhlto.2026.100513_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae018","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis","volume":"17","author":"Krisanapan","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jhlto.2026.100513_bib23","first-page":"16","article-title":"Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors","volume":"27","author":"Grancini","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jhlto.2026.100513_bib24","first-page":"357","article-title":"Single-center evaluation of safety & efficacy of glucagon-like peptide-1 receptor agonists in solid organ transplantation","volume":"32","author":"Sweiss","year":"2022","journal-title":"Progress\u00a0Transpl"},{"key":"10.1016\/j.jhlto.2026.100513_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70246","article-title":"Impact of GLP-1 and GLP-1\/GIP receptor agonist weight loss post-lung transplant on lung allograft function","volume":"39","author":"January","year":"2025","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhlto.2026.100513_bib26","first-page":"342","article-title":"Tolerability and effectiveness of glucagon-like peptide-1 receptor agonists in lung transplant recipients: a single center report","volume":"57","author":"Fishman","year":"2025","journal-title":"Transpl\u00a0Proc"},{"key":"10.1016\/j.jhlto.2026.100513_bib27","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.21037\/jtd-2025-1105","article-title":"Risk factors and clinical outcomes of serum Aspergillus galactomannan antigen (AGA) positivity in lung transplantation","volume":"31","author":"Kamar","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jhlto.2026.100513_bib28","first-page":"38","article-title":"Long term outcomes of lung transplantation in sensitized patients following eculizumab use with the desensitization protocol","volume":"22","author":"Miyashita","year":"2025","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhlto.2026.100513_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10047-025-01539-2","article-title":"Outcomes of venovenous-extracorporeal membrane oxygenation bridging in lung transplant recipients with panel reactive antibody positivity","volume":"29","author":"Chang","year":"2026","journal-title":"J Artif Organs"},{"key":"10.1016\/j.jhlto.2026.100513_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10047-025-01529-4","article-title":"Impact of pre-transplant veno-venous extracorporeal membrane oxygenation on post-lung transplant infections","volume":"29","author":"Kaniuk","year":"2026","journal-title":"J Artif Organs"},{"key":"10.1016\/j.jhlto.2026.100513_bib31","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.21037\/jtd-2025-819","article-title":"Risk factors associated with sternal complication after lung transplantation with transverse sternotomy","volume":"17","author":"Kim","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jhlto.2026.100513_bib32","article-title":"Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunction","author":"Miyashita","year":"2025","journal-title":"Eur\u00a0Respir\u00a0J"},{"key":"10.1016\/j.jhlto.2026.100513_bib33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.tips.2025.08.013","article-title":"Can GLP-1RAs redefine transplantation standard of care?","volume":"46","author":"Almalki","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jhlto.2026.100513_bib34","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.21037\/jtd-24-707","article-title":"Risk factors and impact of swallowing impairment and aspiration after lung transplantation","volume":"16","author":"Graham","year":"2024","journal-title":"J Thorac Dis"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133426000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:38:36Z","timestamp":1779284316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133426000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S2950133426000340"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100513","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonist use and clinical outcomes after lung transplantation: A single-center cohort study","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2026.100513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100513"}}